| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. | Director | Common Stock | 3,306,900 | 22 Jul 2024 | By GC Corp. | ||
| Artiva Biotherapeutics, Inc. | Director | Common Stock | 1,260,512 | 22 Jul 2024 | By GC Cell Corporation | ||
| Artiva Biotherapeutics, Inc. | Director | Series A Preferred Stock | 0 | 22 Jul 2024 | By GC Cell Corporation | ||
| Artiva Biotherapeutics, Inc. | Director | Series A Preferred Stock | 0 | 22 Jul 2024 | By GC Corp. | ||
| Artiva Biotherapeutics, Inc. | Director | Series B Preferred Stock | 0 | 22 Jul 2024 | By GC Cell Corporation | ||
| Artiva Biotherapeutics, Inc. | Director | Series B Preferred Stock | 0 | 22 Jul 2024 | By GC Corp. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARTV | Artiva Biotherapeutics, Inc. | 22 Jul 2024 | 12 | +$30,614,401 | 4 | Director | 22 Jul 2024, 20:22 |
| ARTV | Artiva Biotherapeutics, Inc. | 18 Jul 2024 | 0 | $0 | 3 | Director | 18 Jul 2024, 20:02 |